Author: | Ilson, D. H. |
Article Title: | Cancer of the gastroesophageal junction: Combined modality therapy |
Keywords: | cancer surgery; clinical trial; review; cancer localization; postoperative period; bevacizumab; cisplatin; erlotinib; fluorouracil; cancer combination chemotherapy; multimodality cancer therapy; united states; paclitaxel; cancer radiotherapy; preoperative care; combined modality therapy; neoadjuvant therapy; lymph node metastasis; antineoplastic agent; cancer incidence; adenocarcinoma; bone marrow suppression; esophagitis; mucosa inflammation; nausea; cetuximab; cancer mortality; vinblastine; irinotecan; monoclonal antibody; panitumumab; protein tyrosine kinase inhibitor; celecoxib; cyclooxygenase 2 inhibitor; gefitinib; epirubicin; cancer epidemiology; platinum complex; trastuzumab; mitomycin; esophageal adenocarcinoma; stomach neoplasms; esophageal neoplasms; esophagectomy; lower esophagus sphincter; epidermal growth factor receptor kinase inhibitor; esophagogastric junction; matuzumab |
Journal Title: | Surgical Oncology Clinics of North America |
Volume: | 15 |
Issue: | 4 |
ISSN: | 1055-3207 |
Publisher: | Elsevier Inc. |
Date Published: | 2006-10-01 |
Start Page: | 803 |
End Page: | 824 |
Language: | English |
DOI: | 10.1016/j.soc.2006.07.011 |
PUBMED: | 17030275 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | --- - "Cited By (since 1996): 6" - "Export Date: 4 June 2012" - "CODEN: SOCAF" - "Source: Scopus" |